Td Asset Management Inc Generation Bio Co. Transaction History

Td Asset Management Inc

$102 Billion
Q2 2024

A detailed history of Td Asset Management Inc transactions in Generation Bio Co. stock. As of the latest transaction made, Td Asset Management Inc holds 340,686 shares of GBIO stock, worth $827,866. This represents 0.0% of its overall portfolio holdings.

Number of Shares

340,686

Previous 340,686 -0.0%

Holding current value

$827,866

Previous $1.39 Million 30.74%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.91 - $3.35 $59,979 - $220,805	-65,912 Reduced 16.21%	340,686 $562,000
Q3 2023 Oct 27, 2023	BUY	$3.65 - $6.9 $621,751 - $1.18 Million	170,343 Added 72.1%	406,598 $1.54 Million
Q2 2023 Aug 09, 2023	BUY	$3.5 - $5.67 $16,779 - $27,181	4,794 Added 2.07%	236,255 $1.3 Million
Q3 2022 Nov 07, 2022	BUY	$4.68 - $8.34 $100,620 - $179,310	21,500 Added 10.24%	231,461 $1.18 Million
Q1 2022 May 10, 2022	SELL	$4.16 - $7.76 $115,065 - $214,641	-27,660 Reduced 11.64%	209,961 $1.54 Million
Q4 2021 Feb 10, 2022	BUY	$5.99 - $24.97 $289,203 - $1.21 Million	48,281 Added 25.5%	237,621 $1.68 Million
Q3 2021 Nov 09, 2021	BUY	$20.0 - $27.43 $228,500 - $313,387	11,425 Added 6.42%	189,340 $4.75 Million
Q2 2021 Aug 11, 2021	BUY	$24.34 - $38.34 $498,337 - $784,973	20,474 Added 13.0%	177,915 $3.87 Million
Q1 2021 May 14, 2021	BUY	$24.74 - $40.2 $1.23 Million - $1.99 Million	49,560 Added 45.94%	157,441 $4.48 Million
Q4 2020 Feb 16, 2021	BUY	$21.68 - $51.61 $1.78 Million - $4.24 Million	82,063 Added 317.85%	107,881 $3.06 Million
Q3 2020 Nov 10, 2020	BUY	$18.07 - $31.84 $41,561 - $73,232	2,300 Added 9.78%	25,818 $798,000
Q2 2020 Aug 13, 2020	BUY	$20.1 - $24.69 $472,711 - $580,659	23,518 New	23,518 $494,000

Others Institutions Holding GBIO

# of Institutions

Shares Held

50M

Call Options Held

100

Put Options Held

200

View Full List

About Generation Bio Co.

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $143M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

More about GBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Generation Bio Co. Transaction History